Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
@article{211030,
author = {Satyam Mishra and Vivek Kumar Patel},
title = {Outrunning Precipitation: Supersaturable SNEDDS for Oral Naringenin},
journal = {International Journal of Innovative Research in Technology},
year = {2026},
volume = {13},
number = {6},
pages = {3199-3213},
issn = {2349-6002},
url = {https://ijirt.org/article?manuscript=211030},
abstract = {Naringenin, the citrus flavanone aglycone of naringin, has an unusually broad preclinical pharmacology — antioxidant, anti-inflammatory, antidiabetic, hepatoprotective, cardioprotective and anticancer — and an unusually poor record of clinical translation. The reason is biopharmaceutical rather than pharmacological: an aqueous solubility of the order of tens of micrograms per millilitre, extensive intestinal and hepatic glucuronidation, and susceptibility to intestinal efflux together hold its reported oral bioavailability near the single-digit percent range. A long list of nanocarriers — cyclodextrin complexes, polymeric nanoparticles, nanosuspensions and nanocrystals, liposomes, mixed micelles, solid dispersions, solid lipid nanoparticles, nanostructured lipid carriers and self-nanoemulsifying drug delivery systems (SNEDDS) — has been applied to the problem, with reported gains in oral exposure ranging from roughly two-fold to more than thirteen-fold. Conventional SNEDDS occupy a favourable position in that list, but they share a structural weakness: drug loading is bounded by equilibrium solubility in the oil–surfactant blend, and the fine dispersion formed on dilution in gastrointestinal fluid is a solution that wants to crystallise. Supersaturable SNEDDS (S-SNEDDS) address this directly by incorporating a small proportion of a water-soluble polymeric precipitation inhibitor, converting a transient concentration spike into a sustained, kinetically stabilised supersaturated state — the “spring and parachute”. The approach has repeatedly outperformed its conventional counterpart for paclitaxel, AMG 517, silybin, fenofibrate and curcumin, yet it has not been systematically applied to naringenin. This review consolidates what is known about naringenin’s absorption barriers, audits the delivery systems reported for it, sets out the mechanism and polymer selection logic of supersaturable lipid formulations, and argues that a Quality by Design-optimised naringenin S-SNEDDS is both a rational and an unoccupied position in the field.},
keywords = {Naringenin; supersaturable SNEDDS; precipitation inhibitor; oral bioavailability; lipid-based formulation; Quality by Design; Box–Behnken design},
month = {November},
}
Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.
Join NowNational Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024
Submit inquiry